Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NOMD +4.3%, AVDL +3%
Other news:
- CAN +12.2% (February 2025 Bitcoin Production, Mining Operation Updates, and Preliminary Fourth Quarter 2024 Financial Results)
- CANG +11.1% (Announces February 2025 Production Update for Crypto Mining Business)
- BITF +10.3% (issued its latest monthly production report)
- MLCO +7.4% (Macau Gaming revs)
- PTGX +7% (Protagonist Therapeutics and Takeda (TAK) announce positive topline results from phase 3 verify study of rusfertide in patients with polycythemia vera)
- KALV +3.2% (presentation of novel sebetralstat data related to laryngeal hereditary angioedema attacks and adolescents with HAE at the American Academy of Allergy, Asthma & Immunology/ World Allergy Organization 2025 Joint Congress)
- PSNL +3.1% (New publication from ICR and royal marsden researchers highlights the importance of ultra-sensitive ctDNA testing for early-stage breast cancer recurrence detection)
- VYGR +2.9% (topline data from the Company's single ascending dose trial of VY7523, an investigational anti-tau antibody developed to selectively inhibit the spread of pathological tau in Alzheimer's disease)
- LVS +2.8% (Macau Gaming revs)
- WYNN +2.6% (Macau Gaming revs)
- PHVS +2.6% (presents long-term clinical data of Deucrictibant for the prevention and treatment of HAE attacks at the 2025 AAAAI/WAO Joint Congress)
- RIO +2% (resumes shipping at East Intercourse Island facility at Dampier Port)
- IDYA +1.6% (to collaborate with ATTMOS to accelerate AI/ML-enabled drug discovery for unprecedented first-in-class oncology targets)
- FFIE +1.5% (Announces ‘FF Open AI Day' to Be Held on March 16 That Will Showcase the Company's Current and Future AI Strategy Developments)
- AXSM +1.5% (announces FDA Pre-NDA Meeting minutes for AXS-05 in Alzheimer's Disease agitation supporting NDA submission)
- GSK +1.3% (presents ANCHOR results at 2025 AAAAI; receives BLA review acceptance for Depemokimab)
- EGY +1.3% (Acquires 70% Interest in and Becomes Operator of Offshore Côte D'Ivoire CI-705 Block)
- KEYS +1.3% (Recommended Cash Acquisition of Spirent Communications by Keysight)
- BA +1.2% (The Secretary of State has made a determination approving a possible Foreign military sale to the Government of Israel of munitions, guidance kits, and munitions support and related equipment for an estimated cost of $675.7 mln)
- APGE +1.2% (announces positive interim phase 1 results from the APG990 healthy volunteer trial, unlocking potential maintenance dosing every three and six months for APG279 (APG777 + APG990); provides pipeline progress and reports full year 2024 financial results)
- VIAV +1.1% (acquires Spirent Communications plc's high-speed ethernet and network security testing business)
- MGM +1.1% (Macau Gaming revs)
- QGEN +1% (QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing)